Mankind Pharma Limited (MANKIND.BO)
INR 2846.55
(1.46%)
INR 2846.55
(1.46%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 21.67 Billion | 17.84 Billion | 9.19 Billion | 11.37 Billion | 10.69 Billion | 6 Billion |
| Net Income | 19.12 Billion | 12.81 Billion | 19.74 Billion | 16.91 Billion | 14.37 Billion | 5.78 Billion |
| Depreciation & Amortization | 3.98 Billion | 3.25 Billion | 1.66 Billion | 1.18 Billion | 990.59 Million | 661.69 Million |
| Deferred income taxes | - | -6.6 Billion | - | - | - | - |
| Stock-based compensation | 231.86 Million | 591 Thousand | - | - | - | - |
| Change in working capital | 204.15 Million | 1.66 Billion | -5.86 Billion | -946.33 Million | -1.45 Billion | 650.93 Million |
| Other non-cash items | 8.79 Billion | 6.7 Billion | -6.35 Billion | -5.78 Billion | -3.21 Billion | -1.09 Billion |
| Investing Cash Flow | -21.21 Billion | -10.66 Billion | -13.69 Billion | -12.22 Billion | -4.39 Billion | -4.44 Billion |
| Investments in PPE | -3.89 Billion | -8.32 Billion | -23.45 Billion | -3.12 Billion | -2.27 Billion | -2.97 Billion |
| Acquisitions | 75.07 Million | 22.2 Million | 207.03 Million | 102.7 Million | 52.97 Million | -2.45 Billion |
| Investment purchases | -22.91 Billion | -9.48 Billion | -11.85 Billion | -9.95 Billion | -5.72 Billion | - |
| Sales/Maturities of investments | 5.52 Billion | 7.12 Billion | 16.77 Billion | 3.77 Billion | 4.85 Billion | - |
| Other Investing Activities | -12.29 Million | -4.09 Million | 4.63 Billion | -3.01 Billion | -1.29 Billion | 983.8 Million |
| Financing Cash Flow | 306.54 Million | -6.98 Billion | 6.04 Billion | -78.11 Million | -5.3 Billion | -2.27 Billion |
| Debt repayment | -339.63 Million | -6.95 Billion | -6.53 Billion | -4.68 Billion | -2.14 Billion | -224.16 Million |
| Dividends payments | - | - | - | - | -3.64 Billion | -240.35 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 86.29 Million | -7.11 Billion | 12.58 Billion | 4.6 Billion | 481.1 Million | -2.26 Billion |
| Accounts receivables | -2.89 Billion | -2.05 Billion | -659.53 Million | 2 Billion | -3.08 Billion | 703.22 Million |
| Accounts payables | 974.52 Million | -650.19 Million | 4.19 Billion | -781.53 Million | 1.83 Billion | - |
| Inventory | -550.03 Million | 2.61 Billion | -5.76 Billion | -2.84 Billion | -781.49 Million | -304.95 Million |
| Other working capital | 2.67 Billion | 1.75 Billion | -3.63 Billion | 676.93 Million | 586.09 Million | 252.66 Million |
| Cash at beginning of period | 3.04 Billion | 3.02 Billion | 1.27 Billion | 2.19 Billion | 1.16 Billion | 1.88 Billion |
| Cash at end of period | 11.97 Billion | 3.04 Billion | 2.83 Billion | 1.27 Billion | 2.19 Billion | 1.16 Billion |
| Capital Expenditure | -3.89 Billion | -8.32 Billion | -23.45 Billion | -3.12 Billion | -2.27 Billion | -2.97 Billion |
| Effect of forex changes on cash | 11.66 Million | 23.15 Million | 4.78 Million | 3.75 Million | 36.04 Million | -240 Thousand |
| Net cash flow / Change in cash | 8.93 Billion | 22.86 Million | 1.55 Billion | -924.03 Million | 1.03 Billion | -719.91 Million |
| Free Cash Flow | 17.77 Billion | 9.52 Billion | -14.25 Billion | 8.24 Billion | 8.41 Billion | 3.02 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.36 Billion | 4.71 Billion | 19.12 Billion | 4.53 Billion | 5.01 Billion | 4.86 Billion |
| Depreciation & Amortization | - | - | 3.98 Billion | 1.09 Billion | 964.84 Million | 873.54 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 231.86 Million | 231.86 Million | - | - | - |
| Change in working capital | - | - | 204.15 Million | - | - | - |
| Other non-cash items | -5.36 Billion | -4.94 Billion | 8.79 Billion | -4.53 Billion | -5.01 Billion | -4.86 Billion |
| Investing Cash Flow | - | - | -21.21 Billion | - | - | - |
| Investments in PPE | - | - | -3.89 Billion | - | - | - |
| Acquisitions | - | - | 75.07 Million | - | - | - |
| Investment purchases | - | - | -22.91 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 5.52 Billion | - | - | - |
| Other Investing Activities | - | - | -12.29 Million | - | - | - |
| Financing Cash Flow | - | - | 306.54 Million | - | - | - |
| Debt repayment | - | - | -339.63 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 86.29 Million | - | - | - |
| Accounts receivables | - | - | -2.89 Billion | - | - | - |
| Accounts payables | - | - | 974.52 Million | - | - | - |
| Inventory | - | - | -550.03 Million | - | - | - |
| Other working capital | - | - | 2.67 Billion | - | - | - |
| Cash at beginning of period | - | - | 3.04 Billion | 2.53 Billion | 605.17 Million | 3.04 Billion |
| Cash at end of period | - | - | 11.97 Billion | 4.72 Billion | 2.53 Billion | 4.79 Billion |
| Capital Expenditure | - | - | -3.89 Billion | - | - | - |
| Effect of forex changes on cash | - | - | 11.66 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 8.93 Billion | 2.19 Billion | 1.92 Billion | 1.74 Billion |
| Free Cash Flow | - | - | 17.77 Billion | 2.19 Billion | 1.92 Billion | 1.74 Billion |
RCC
KHNGF
IMCC
VICA
OXY-WT
ACNNF